Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIR-MI: Ischemia and Remodeling after Acute MI
NCT00162331Phase 4Completed
- Sponsor
- Lantheus Holdings, Inc.
- Start
- Jan 2005
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 4, open-label, single-arm trial of technetium-99m sestamibi in myocardial infarction (MI), sponsored by Lantheus Holdings, Inc. Primary endpoint: Interactions between abnormalities in blood supply and changes in heart size at 6 months. Started Jan 2005; status: completed.
02
Drugs
technetium-99m sestamibi
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00162331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00162331.